3.05
5.57%
-0.18
Aprea Therapeutics Inc Azioni (APRE) Dati Finanziari
Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
Durata del periodo | 3 mesi | 3 mesi | 3 mesi | 3 mesi | 3 mesi |
Revenues |
2,604%
0.3806
|
0.0141 | 0.3195 | 0.2497 | - |
Operating Expenses |
4.30%
3.5302
|
3.689 | 3.8423 | 3.9014 | 4.6225 |
Benefits Costs and Expenses |
7.71%
3.1907
|
3.4573 | 3.524 | 3.5088 | 4.3799 |
Costs And Expenses |
4.30%
3.5302
|
3.689 | 3.8423 | 3.9014 | 4.6225 |
Operating Income/Loss |
14.29%
-3.1497
|
-3.6749 | -3.5229 | -3.6517 | -4.6225 |
Income/Loss From Continuing Operations Before Tax |
18.39%
-2.8101
|
-3.4433 | -3.2045 | -3.2591 | -4.3799 |
Income Tax Expense/Benefit |
-
|
- | - | - | - |
Income/Loss From Continuing Operations After Tax |
18.39%
-2.8101
|
-3.4433 | -3.2045 | -3.2591 | -4.3799 |
Net Income/Loss
|
18.39%
-2.8101
|
-3.4433 | -3.2045 | -3.2591 | -4.3799 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
10,363%
4.1983
|
0.0401 | 3.7352 | 3.7316 | 3.2605 |
Diluted Average Shares |
10,056%
4.1983
|
0.0413 | 3.7316 | 3.7316 | 3.2605 |
Basic Earnings Per Share |
27.17%
-0.67
|
-0.92 | -0.86 | -0.87 | -1.34 |
Diluted Earnings Per Share |
27.17%
-0.67
|
-0.92 | -0.85 | -0.87 | -1.34 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):